Rebuilding Health with Preemptive Care

Hematologist/oncologist and palliative medicine physician who co-leads an organization focused on dramatically accelerating timelines for understanding what clinical interventions work for whom and when. Her areas of research and expertise include cancer data, real world evidence, clinical trials, healthcare policy and regulation, health services research, patient reported outcomes (PROs), clinical informatics, and patient-centered care. Amy was professor of medicine at Duke, principal deputy commissioner of the FDA and chief medical officer at Verily and Flatiron Health.

Finance executive with a strong record of success helping healthcare entities achieve their financial goals. Greg was formerly Vice President, Finance at Intermountain Health where he was responsible for the financial operations of its hospitals, clinics, and health plan.

Early adopter and expert in the clinical practice of lifestyle medicine, Liz previously served as Senior Medical Director for Wellness and Nutrition at Intermountain Health. She is a past president of the American College of Sports Medicine (ACSM) and now chairs their Exercise Is Medicine Governance Committee and serves on the Board of Directors.

Doctor of Internal Medicine, Jim is a builder of sustainable clinical systems. Skilled at physician coaching and development, conflict resolution, and designing healthcare strategies, Jim was formerly the Chief Medical Officer of Scripps Health.

Researcher and innovator who has spent his career on work that identifies early risk and intercepts disease. Ben formerly was the Founding Partner of Connected World Without Disease Accelerator as well as held various senior leadership roles at J&J and Janssen.

Researcher focused on using computational methods (AI, data science, informatics) to address problems relevant to medicine with a focus on understanding drug actions at molecular, cellular, organism and population levels. Russ helps lead an FDA-supported Center of Excellence in Regulatory Science & Innovation and is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science at Stanford University.

Physician and Sociologist who conducts research in the areas of social networks and biosocial science. He is the Sterling Professor of Social and Natural Science at Yale University, where he directs the Human Nature Lab. He is the co-author of the book Connected, a foundational work on social networks and their influence on our everyday lives, and the New York Times bestseller, Blueprint: The Evolutionary Origins of a Good Society. Nick’s portrait is based on a photo courtesy of Big Think.

Clinician who develops and applies computational techniques to address disease at multiple scales: from whole healthcare systems as “living laboratories” to the functional genomics of neurodevelopment. Zak is Chair of the Department of Biomedical Informatics and the Marion V. Nelson Professor of Biomedical Informatics at Harvard Medical School.

Strategist and architect of data-driven healthcare products, Scott designed a factory approach to building healthcare businesses. He is the former technology lead for UnitedHealth R&D and has developed multiple novel behavior-change programs and businesses.

Pediatrician turned healthcare executive, Mark has seen success in clinical practice and innovation, including serving as the chief physician executive for Intermountain Health and serving as a board director for its health plan, Select Health.

Pediatrician turned healthcare executive, Mark has seen success in provider excellence and innovation, including with health plan Select Health and serving as board trustee for healthcare operations as chief physician executive of Intermountain Health.

Mark is committed to making it easier for people to access care that drives better health. As a Doctor of Pharmacy, Mark has spent his career in patient care, operations, and government, most recently serving as a senior advisor to the CMS Administrator and on Operation Warp Speed (the federal COVID vaccine program). At Lore, Mark is applying his deep experience in improving access to care and medication to serve our beneficiaries and their providers.

Strategic designer and leader of innovative healthcare payment solutions. Mark was previously a senior advisor to the CMS administrator for prescription drug pricing, the CMS Innovation center, and Operation Warp Speed for vaccine and therapeutic access.

Risk manager for numerous start-up products and companies, Mike led actuarial risk and insurance design for the Motion, All Savers, and Level2 insurance products. He was previously an Executive Vice President at UnitedHealth Group.

Founder of multiple businesses built on the risk models that drive the healthcare industry, including the Motion, All Savers, and Level2 insurance products. Ken was previously the Chief Scientific Officer of UnitedHealth Group while leading research and development.

Founder of multiple businesses built on the risk models that drive the healthcare industry, including the Motion, All Savers, and Level2 insurance products. Ken was previously the Chief Scientific Officer of UnitedHealth Group while leading research and development.

Industry leader in provider operations and financial growth, Shiraz has a background in the financial sector, has led innovative product launches across large health systems, and was previously the Chief Operations Officer of Scripps Health.

Chief technology officer for numerous risk products and companies with successful exits, including Motion, All Savers, and various UHG R&D builds. Mark was formerly co-founder of Savvysherpa and Chief Technology Officer of OptumLabs.

Expert in the intersection of machine-learning (ML) and behavioral health with experience across numerous mobile, healthcare, and biosensor applications. Sara is a former ML Engineer at Apple and Turi and is an award-winning mobile game designer.

Rushika is a practicing physician and co-founder and CEO of Iora Health, which was acquired by One Medical and eventually Amazon. Prior to redesigning primary care with Iora, he served as the first Executive Director of Harvard’s Interfaculty Program for Health Systems Improvement.

Amy is a managing partner at Polaris Partners and founder of the Polaris Innovation Fund, which invests in healthcare and early stage biotech start-ups. Additionally, she serves as chair of the Board of Directors of Alnylam Pharmaceuticals, among other board director positions, and previously served as president of Pfizer Nutrition and Pfizer Consumer Healthcare.

Dave is the co-founder of the private equity fund Jory Capital, serves as a member of the Temasek Americas Advisory Panel, and is a public company director for Boston Scientific and Privia Health. He was previously the CEO and board member of UnitedHealth Group and a Partner of Arthur Andersen.

Bert served for 20 years as Executive Vice President and CFO of Intermountain Healthcare, where he oversaw financial operations as well as venture development and innovation strategies. He currently serves on boards of several private equity companies and the Intermountain Foundation and chairs the board of Culmination Bio, Inc.